An Adverse Drug Reaction Database for Clinical Use - Potential of and Difficulties with the Summary of Product Characteristics

Stud Health Technol Inform. 2022 May 25:294:450-454. doi: 10.3233/SHTI220499.

Abstract

Adverse drug reactions (ADRs) for all drugs in Europe are described in the legally approved Summary of Product Characteristics (SmPC). An overview of all ADRs of the patients' drug list can support healthcare staff to link patient symptoms to possible ADRs. We review the possibilities and challenges to extract ADR information from SmPCs and present the development of our semi-automated procedure for extraction of ADRs from the tabulated section of the SmPCs to create a database, named Bikt, which is regularly updated and used at point of care in Sweden. The existence of five major table formats for ADRs used in the SmPCs required the development of different parsing scripts. Manual checks for correctness for all content has to be performed. The quality of extraction was investigated for all SmPCs by measuring precision, recall and F1 scores (i.e. the weighted harmonic mean of precision and recall) and compared with other methods published. We conclude that it is possible to semi-automatically extract ADR information from SmPCs. However, clear technical and content guidelines and standards for ADR tables and terms from drug registration authorities would lead to improved extraction and usability of ADR information at point of care.

Keywords: ADR-database; Adverse drug reaction; Summary of Product Characteristics; clinical decision support; data extraction; knowledge bases.

Publication types

  • Review

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Databases, Factual*
  • Drug-Related Side Effects and Adverse Reactions*
  • Europe
  • Humans